PEGASYS

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug PEGASYS contains one active pharmaceutical ingredient (API):

1
UNII Q46947FE7K - PEGINTERFERON ALFA-2A
 

Peginterferon alpha-2a is a pegylated interferon alfa-2a that possesses the in vitro antiviral and antiproliferative activities that are characteristic of interferon alfa-2a. Peginterferon alpha-2a is indicated for the treatment of hepatitis B and C.

 
Read more about Peginterferon alpha-2a

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 PEGASYS Solution for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L03AB11 Peginterferon alfa-2a L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 11037X, 11416W, 6439X, 6449K, 9515T, 9516W
BR Câmara de Regulação do Mercado de Medicamentos 529204002151210
CA Health Products and Food Branch 02248077
EE Ravimiamet 1110340, 1110351, 1110362, 1110373, 1110384, 1110395, 1110407, 1110418, 1214828, 1214839, 1609523, 1609534, 1609545, 1609556, 1609567, 1609578, 1646197, 1820281, 1843905, 1847853, 1888274
ES Centro de información online de medicamentos de la AEMPS 02221006, 02221008, 102221017
FI Lääkealan turvallisuus- ja kehittämiskeskus 008767, 008782
FR Base de données publique des médicaments 64347476, 67042907, 67134227
GB Medicines & Healthcare Products Regulatory Agency 226859, 43381, 43384
HK Department of Health Drug Office 51529, 51530
IE Health Products Regulatory Authority 88365, 88402
IT Agenzia del Farmaco 035683034, 035683046, 035683059, 035683061, 035683073, 035683085, 035683150
JP 医薬品医療機器総合機構 6399419A1022, 6399419A2029
LT Valstybinė vaistų kontrolės tarnyba 1004853, 1011191, 1011192, 1011193, 1011194, 1011195, 1030176, 1030177, 1030178, 1030179, 1064244, 1064245, 1064246, 1064247, 1064248, 1064249, 1071714
NL Z-Index G-Standaard 14753588, 14753596
NL Z-Index G-Standaard, PRK 105740, 106364, 106372, 63533, 63541
NZ Medicines and Medical Devices Safety Authority 10133
PL Rejestru Produktów Leczniczych 100112598, 100112606, 100112612, 100112629, 100295825
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W68070001, W68070002, W68070003
SG Health Sciences Authority 12313P, 12314P
TN Direction de la Pharmacie et du Médicament 4773014H
TR İlaç ve Tıbbi Cihaz Kurumu 8699514950004, 8699514950257, 8699514950264, 8699514950271
US FDA, National Drug Code 0004-0350, 0004-0357
ZA Health Products Regulatory Authority 38/26/0180

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.